GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy

Drug resistance constitutes one of the main obstacles for clinical recovery of acute myeloid leukemia (AML) patients. Therefore, the treatment of AML requires new strategies, such as adding a third drug. To address whether GATA2 could act as a regulator of chemotherapy resistance in human leukemia c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li, Sun, Hanxiao, Cao, Yanan, Xuan, Binbin, Fan, Yingchao, Sheng, Huiming, Zhuang, Wenfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256934/
https://www.ncbi.nlm.nih.gov/pubmed/28114350
http://dx.doi.org/10.1371/journal.pone.0170630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256934/
https://www.ncbi.nlm.nih.gov/pubmed/28114350
http://dx.doi.org/10.1371/journal.pone.0170630

Ejemplares similares